Breast Implant-Associated Malignancies: Current Recommendations for Workup and Management

By afschroeder • April 30, 2026

Fracol ME, Miranda RN, Tsao AS, Rodriguez MM, Nastoupil LJ, Young PA, Sherrod AE, LeBlanc DM, Hunsicker LM, Bacchi CE, Gabriel T, Myckatyn TM, Tanaka S, Kuykendall LV, Resetkova E, Evans MG, Jagasia P, McCarthy CM, Santanelli Di Pompeo F, Hunt KK, Medeiros LJ, Haymaker C, Clemens MW. Breast Implant-Associated Malignancies: Current Recommendations for Workup and Management. Plast Reconstr Surg. 2026 May 1;157(5):774e-784e. doi: 10.1097/PRS.0000000000012796. Epub 2026 Apr 29. PMID: 42054062.

Tags: Hematology/Oncology, Publications

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial

Socinski MA, Stahel R, Lee DH, Cappuzzo F, Nishio M, Lovly CM, Ozyilkan O, Li Q, Johnson M, Garon EB, Kilickap S, Ferreira da Silva[...]

The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond

Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate[...]

Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers?

Shachar EK, Silverstein J, Kwan L, Salani R, Karlan BY, Chase DM. Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers? Gynecol[...]